I-Capreomycin CAS:11003-38-6

I-Capreomycin isetshenziswa kakhulu ekwelapheni isifo sofuba, ikakhulukazi lapho kubhekene nezinhlobo zebhaktheriya i-Mycobacterium tuberculosis ezingamelani nemithi. Ngokuvamile iyingxenye yohlelo lokwelapha oluhlanganisiwe olusetshenziselwa ukulwa nesifo sofuba esingamelana nemithi eminingi (MDR-TB) noma izimo zesifo sofuba esingamelana nemithi eminingi (XDR-TB) lapho ama-antibiotic okuqala endabuko ehlulekile khona. Ukunikezwa kwe-Capreomycin kuvame ukwenziwa ngomjovo we-intramuscular futhi kuqashwe ngokucophelela ochwepheshe bezempilo ngenxa yokuthi kungenzeka kube nemiphumela emibi ehambisana nama-antibiotic e-aminoglycoside. Isikhathi sokwelashwa kanye nomthamo kunqunywa ngokusekelwe ebunzimeni bokutheleleka, isisindo sesiguli, ukusebenza kwezinso, kanye nesimo sempilo iyonke. Ukuqapha njalo ukusebenza kwezinso, ukuzwa, kanye nemiphumela emibi engaba khona kubalulekile ngesikhathi sokwelashwa kwe-Capreomycin ukuqinisekisa ukuphepha kwesiguli kanye nokusebenza kahle kokwelashwa. Ukunamathela ohlelweni lokwelashwa olunqunyiwe kubalulekile ukuze kufezwe imiphumela emihle futhi kuncishiswe ingozi yokuthuthukisa ukumelana okuqhubekayo. Iziguli ezelashwa nge-Capreomycin kufanele zilandele iseluleko sezokwelapha ngenkuthalo futhi ziqedele inkambo ephelele yama-antibiotic ukuze kuvinjelwe ukwehluleka kokwelashwa noma ukuphinda kwesifo sofuba. Ukubambisana okuseduze nabahlinzeki bezempilo, kanye nokuhlolwa njalo nokuqapha, kubalulekile ekuphatheni isifo sofuba ngempumelelo nge-Capreomycin ngenkathi kunciphisa ingozi yezinkinga futhi kukhuthaze ukululama.